Literature DB >> 15985579

CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics.

J Wan1, R Khanna, M Sandusky, D M Papazian, J C Jen, R W Baloh.   

Abstract

BACKGROUND: CACNA1A encodes CaV2.1, the pore-forming subunit of P/Q-type voltage-gated calcium channel complexes. Mutations in CACNA1A cause a wide range of neurologic disturbances variably associated with cerebellar degeneration. Functional studies to date focus on electrophysiologic defects that do not adequately explain the phenotypic findings.
OBJECTIVE: To investigate whether some missense mutations might interfere with protein folding and trafficking, eventually leading to protein aggregation and neuronal injury.
METHODS: The authors studied the functional consequences of two pore missense mutations, C287Y and G293R, in two families with EA2, one newly discovered and the other previously reported. Both mutations caused episodic and interictal ataxia. The biophysical properties of mutant and wild type calcium channels were examined by whole-cell patch-clamp recordings in transfected COS-7 cells. The plasma membrane targeting was visualized by confocal fluorescence imaging on CaV2.1 tagged with green fluorescent protein.
RESULTS: The mutant channels exhibited a marked reduction in current expression and deficiencies in plasma membrane targeting.
CONCLUSIONS: In addition to altered channel function, the deficiency in protein misfolding and trafficking associated with the C287Y and G293R mutants may contribute to the slowly progressive cerebellar ataxia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985579     DOI: 10.1212/01.WNL.0000167409.59089.C0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Authors:  M Strupp; R Kalla; J Claassen; C Adrion; U Mansmann; T Klopstock; T Freilinger; H Neugebauer; R Spiegel; M Dichgans; F Lehmann-Horn; K Jurkat-Rott; T Brandt; J C Jen; K Jahn
Journal:  Neurology       Date:  2011-07-06       Impact factor: 9.910

Review 2.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

3.  Dominant-negative suppression of Cav2.1 currents by alpha(1)2.1 truncations requires the conserved interaction domain for beta subunits.

Authors:  Robert S Raike; Holly B Kordasiewicz; Randall M Thompson; Christopher M Gomez
Journal:  Mol Cell Neurosci       Date:  2006-12-11       Impact factor: 4.314

4.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

Review 5.  Episodic ataxia type 2.

Authors:  Michael Strupp; Andreas Zwergal; Thomas Brandt
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 6.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

7.  A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx.

Authors:  Maria Isabel Bahamonde; Selma Angèlica Serra; Oliver Drechsel; Rubayte Rahman; Anna Marcé-Grau; Marta Prieto; Stephan Ossowski; Alfons Macaya; José M Fernández-Fernández
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

8.  Association of A Novel Splice Site Mutation in P/Q-Type Calcium Channels with Childhood Epilepsy and Late-Onset Slowly Progressive Non-Episodic Cerebellar Ataxia.

Authors:  Claudia Stendel; Maria Cristina D'Adamo; Manuela Wiessner; Marina Dusl; Marta Cenciarini; Silvia Belia; Ehsan Nematian-Ardestani; Peter Bauer; Jan Senderek; Thomas Klopstock; Mauro Pessia
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

9.  Myotonia congenita mutation enhances the degradation of human CLC-1 chloride channels.

Authors:  Ting-Ting Lee; Xiao-Dong Zhang; Chao-Chin Chuang; Jing-Jer Chen; Yi-An Chen; Shu-Ching Chen; Tsung-Yu Chen; Chih-Yung Tang
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

Review 10.  Genetic neurological channelopathies: molecular genetics and clinical phenotypes.

Authors:  J Spillane; D M Kullmann; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.